2 completed, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Multi-drug Resistant Tuberculosis: new trials by email Literature Review of Multi-drug Resistant Tuberculosis trials Research Report on Multi-drug Resistant Tuberculosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid Pretomanid - Multi-drug Resistant Tuberculosis | Phase 1 | Completed | Global Alliance for TB Drug Development | 48 | 2020-01-14 | 2024-07-24 |
| Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells The adoptive treatment of allogeneic γδT cells, Control, Conventional treatment - Multi-drug Resistant Tuberculosis | Phase 1 | Unknown | Zhinan Yin, Ph.D. | 45 | 2018-06-01 | 2018-07-02 |
| TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB Linezolid, Placebo - Multi-drug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 36 | 2009-04-01 | 2026-07-06 |
Tuberculosis, Multidrug-Resistant (3) · Extensively Drug-Resistant Tuberculosis (2) · Anemia (1) · Optic Nerve Diseases (1) · Peripheral Nervous System Diseases (1) · Thrombocytopenia (1)
Actinomycetales Infections (3) · Bacterial Infections (3) · Bacterial Infections and Mycoses (3) · Gram-Positive Bacterial Infections (3) · Infections (3) · Mycobacterium Infections (3) · Tuberculosis (3) · Blood Platelet Disorders (1) · Cranial Nerve Diseases (1) · Cytopenia (1) · Eye Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Nervous System Diseases (1) · Neuromuscular Diseases (1)
Linezolid (1) · pretomanid (1) · stearic acid (1)
Centers for Disease Control and Prevention (1) · Global Alliance for TB Drug Development (1) · Zhinan Yin, Ph.D. (1)
China (1) · South Africa (1) · United States (1)
Antonio Lombardi, MD (1) · Guofang Deng, Master (1) · Jussi Saukkonen, MD (1) · Nesri Padayachin, MBChB (1) · Waffa El-Sadr, MD (1)